Hepion Pharmaceuticals (HEPA) holder reports 10M warrants and 10M shares
Rhea-AI Filing Summary
Black Global 5 LLC, a more-than-10% owner of Hepion Pharmaceuticals, reports initial holdings consisting of 10,000,000 warrants exercisable at $0.0600 per share for an equal number of common shares, expiring August 3, 2031, and 10,000,000 shares of Hepion common stock held indirectly. Black Global 5 LLC is managed by Red Global 3 LLC, each entity 100% owned by Darin Feinstein.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Black Global 5 LLC
Role
10% Owner
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Warrants F1 | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Warrants — 10,000,000 shares (Direct);
Common Stock — 10,000,000 shares (Indirect, (1) See Footnote)
Footnotes (1)
- F1. Black Global 5, LLC is managed by Red Global 3, LLC, each of which entity is 100% owned by Darin Feinstein
Key Figures
Warrants held: 10,000,000
Underlying common shares for warrants: 10,000,000
Exercise price of warrants: 0.0600
+2 more
5 metrics
Warrants held
10,000,000
Number of Hepion warrants held directly by Black Global 5 LLC
Underlying common shares for warrants
10,000,000
Underlying Hepion common shares for the reported warrants
Exercise price of warrants
0.0600
Exercise price per share for the Hepion warrants
Warrant expiration date
2031-08-03
Expiration date of the reported Hepion warrants
Indirect common shares held
10,000,000
Indirectly held Hepion Pharmaceuticals common shares
Key Terms
Warrants, underlying security, indirect ownership, more-than-10% owner
4 terms
Warrants financial
"security_title: Warrants with an exercise price of $0.0600 per share"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.
underlying security financial
"underlying_security_title: Common Stock with 10,000,000 underlying shares"
indirect ownership financial
"Common Stock entry shows indirect ownership of 10,000,000 shares"
more-than-10% owner financial
"Reporting person is flagged as a more-than-10% owner of the issuer"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the HEPA Form 3 filed by Black Global 5 LLC disclose?
The Form 3 shows Black Global 5 LLC as a more-than-10% owner of Hepion Pharmaceuticals, reporting 10,000,000 warrants at $0.0600 per share and 10,000,000 shares of common stock as its initial beneficial holdings.
How many Hepion Pharmaceuticals (HEPA) warrants does Black Global 5 LLC report?
Black Global 5 LLC reports holding 10,000,000 warrants for Hepion common stock. These warrants have an exercise price of $0.0600 per share and are exercisable for 10,000,000 underlying common shares, with an expiration date of August 3, 2031.
What common stock position in HEPA is reported by Black Global 5 LLC?
The filing reports that Black Global 5 LLC has an indirect holding of 10,000,000 shares of Hepion Pharmaceuticals common stock. The ownership is marked as indirect, with a notation to see a footnote describing the ownership structure and related entities.
What is the exercise price and expiration date of the HEPA warrants?
The warrants held by Black Global 5 LLC are exercisable at an exercise price of $0.0600 per share and have an expiration date of August 3, 2031. Each warrant is linked to one underlying share of Hepion common stock, according to the filing details.
Who controls Black Global 5 LLC in the HEPA Form 3 disclosure?
The footnote states that Black Global 5 LLC is managed by Red Global 3 LLC, and that each of these entities is 100% owned by Darin Feinstein. The securities reported are therefore held through these entities rather than directly by an individual.